Skip to content
10-Q

Quarterly Report

NGM BIOPHARMACEUTICALS INC

0001628280-23-027217

← back to feed
Filed
Aug 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 31, 2023 82.72M sh
Shares Diluted Q2 2023 · Jun 30, 2023 82.46M sh
Shares Diluted Q2 2023 · Jun 30, 2023 82.23M sh
Shares Diluted Q2 2023 · Jun 30, 2022 79.27M sh
Shares Diluted Q2 2023 · Jun 30, 2022 78.65M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$82.08M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$85.89M
Short Term Investments Q2 2023 · Jun 30, 2023 $140.27M
Short Term Investments Q2 2023 · Dec 31, 2022 $198.04M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $53.27M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $73.46M
Stockholders Equity Q2 2023 · Jun 30, 2023 $192.12M
Stockholders Equity Q2 2023 · Mar 31, 2023 $220.93M
Stockholders Equity Q2 2023 · Dec 31, 2022 $259.56M
Stockholders Equity Q2 2023 · Jun 30, 2022 $292.08M
Stockholders Equity Q2 2023 · Mar 31, 2022 $311.14M
Stockholders Equity Q2 2023 · Dec 31, 2021 $335.65M
Current Liabilities Q2 2023 · Jun 30, 2023 $28.42M
Current Liabilities Q2 2023 · Dec 31, 2022 $47.84M
Total Liabilities Q2 2023 · Jun 30, 2023 $28.42M
Total Liabilities Q2 2023 · Dec 31, 2022 $47.84M
Current Assets Q2 2023 · Jun 30, 2023 $204.4M
Current Assets Q2 2023 · Dec 31, 2022 $288.86M
Total Assets Q2 2023 · Jun 30, 2023 $220.54M
Total Assets Q2 2023 · Dec 31, 2022 $307.4M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.46
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.04
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.59
Eps Diluted Q2 2023 · Jun 30, 2022 −$1.00
Eps Basic Q2 2023 · Jun 30, 2023 −$0.46
Eps Basic Q2 2023 · Jun 30, 2023 −$1.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.59
Eps Basic Q2 2023 · Jun 30, 2022 −$1.00
Sga Expense Q2 2023 · Jun 30, 2023 $9.65M
Sga Expense Q2 2023 · Jun 30, 2023 $21.23M
Sga Expense Q2 2023 · Jun 30, 2022 $9.93M
Sga Expense Q2 2023 · Jun 30, 2022 $20.65M
Rd Expense Q2 2023 · Jun 30, 2023 $32.35M
Rd Expense Q2 2023 · Jun 30, 2023 $73.21M
Rd Expense Q2 2023 · Jun 30, 2022 $45.43M
Rd Expense Q2 2023 · Jun 30, 2022 $88.24M
Net Income Q2 2023 · Jun 30, 2023 −$38.26M
Net Income Q2 2023 · Jun 30, 2023 −$85.91M
Net Income Q2 2023 · Mar 31, 2023 −$47.65M
Net Income Q2 2023 · Jun 30, 2022 −$46.52M
Net Income Q2 2023 · Jun 30, 2022 −$78.97M
Net Income Q2 2023 · Mar 31, 2022 −$32.45M
Operating Income Q2 2023 · Jun 30, 2023 −$40.58M
Operating Income Q2 2023 · Jun 30, 2023 −$90.77M
Operating Income Q2 2023 · Jun 30, 2022 −$47.07M
Operating Income Q2 2023 · Jun 30, 2022 −$79.65M
Revenue Q2 2023 · Jun 30, 2023 $1.42M
Revenue Q2 2023 · Jun 30, 2023 $3.67M
Revenue Q2 2023 · Jun 30, 2022 $8.29M
Revenue Q2 2023 · Jun 30, 2022 $29.24M